Salute e Benessere

Valneva to Meet with Investors during the J.P. Morgan Healthcare Conference

Saint Herblain (France), January 6, 2025–Valneva SE(Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announces that members of its management team will meet one-on-one with existing shareholders and hold meetings with other institutional specialist investors during the 43nd Annual J.P. Morgan Healthcare Conference, January 13-15, 2025 in San Francisco.Valneva's CEO Thomas Lingelbach and CFO Peter Bühler will discuss the Company's commercial portfolio of vaccines,...
Nasdaq GlobeNewswire
06/01/2025

EUROAPI welcomes the French Minister for Health and Access to Healthcare Yannick…

Press Release A tour of Vertolaye manufacturing and storage facilities highlighted EUROAPI's long-term commitment to health sovereigntyParis and Vertolaye - January 6, 2025 –The French Minister for Health and Access to Healthcare Yannick Neuder and the French Minister for Industry and Energy Marc Ferracci visited today EUROAPI's industrial site in Vertolaye (Puy-de-Dôme), accompanied by members of parliament and local elected representatives.The Vertolaye plant...
Nasdaq GlobeNewswire
06/01/2025

Rabies Vaccine Market Size to Reach USD 2.3 Billion by 2030, Witnessing a CAGR…

IMR
06/01/2025

Companion Animal Diagnostics Market to Hit US$ 4.55 Billion by 2029 with 8.8%…

Browse in-depth TOC on "Companion Animal Diagnostics Market" Browse in-depth TOC on "Companion Animal Diagnostics Market" 528 - Tables 61 - Figures 422 - Pages In this report, the companion animal diagnostics market has been segmented based on product, technology, animal type, application, end user and region. The companion animal diagnostics market is segmented into consumables and instruments based on product. Consumables segment accounted for the largest share of global...
PR Newswire
06/01/2025

Zero Candida Announces Plans to Complete Preclinical Studies for FDA Submission…

The company has successfully completed a two sheep protocol pilot trial in November 2023, and is now preparing to expand the study. The ZC-1-A device was confirmed as 100% safe for use, with findings concluded from the Shamir Medical Center. The company has successfully completed a two sheep protocol pilot trial inNovember 2023, and is now preparing to expand the study. The ZC-1-A device was confirmed as 100% safe for use, with findings concluded from the Shamir Medical Center. ...
PR Newswire
06/01/2025

Renovaro to Acquire Predictive Oncology in All-Stock Transaction

Acquisition provides access to critical resources encompassing a biobank of more than 150,000 tumor specimens, 200,000 pathology slides and decades of longitudinal drug response dataData provides a critical pathway to progress AI using the high-speed computing power provided through collaboration with Nebul Combines Predictive Oncology's AI-driven multi-omic drug discovery platform with Renovaro's AI Cube multi-omic artificial intelligence to advance both cancer diagnostics and early...
Nasdaq GlobeNewswire
06/01/2025

EMSRUN Medical Celebrates 15 Years of Excellence in Life-Saving Solutions

Innovative Research and Efficient Delivery Innovative Research and Efficient Delivery EMSRUN's integrated approach to research, development, and manufacturing combines cutting-edge innovation with operational excellence. The company's dedicated R&D team drives continuous development of new products precisely tailored to evolving market demands. Through advanced inventory, logistics, and transportation management systems, EMSRUN ensures accurate and timely delivery to customers...
PR Newswire
06/01/2025

Tecan to present at upcoming Investor Conferences

Männedorf, Switzerland, January 6, 2025– The Tecan Group (SIX Swiss Exchange: TECN) today announced that it will attend and present at the following investor conferences in the upcoming weeks: Baader Helvea Swiss Equities Conference, Bad Ragaz, SwitzerlandDate: 9 January 2025Participants: Dr. Achim von Leoprechting, CEO Tania Micki, CFO Martin Brändle, SVP, Corp. Comm. & Investor Relations Not webcasted. Octavian Seminar 2025, Davos, SwitzerlandDate: 10 January...
Nasdaq GlobeNewswire
06/01/2025

Tilray Medical Wins Tender to Supply Luxembourg with Medical Cannabis

Tilray Medical , a division of Tilray Brands, Inc. (Nasdaq: TLRY; TSX: TLRY), proudly announces that its German subsidiary,Tilray Deutschland GmbH, has secured a tender to supply Luxembourg with its high-quality cannabis flower. The granting of this tender by theMinistry of Healthand Social Security for the Grand Duchy of Luxembourghighlights the trust placed in Tilray Medical to deliver high-quality medical cannabis on a consistent basis across the global medical cannabis industry...
Nasdaq GlobeNewswire
06/01/2025

Novo Holdings Participates in €90 Million Series A Financing Round for Orbis…

Novo Holdings Partner, Morten Graugaard, to lead Orbis as CEO Novo Holdings Partner,Morten Graugaard, to lead Orbis as CEO COPENHAGEN, Denmark , Jan. 6, 2025 /PRNewswire/ -- Novo Holdings today announced its participation in a €90 million Series A financing for Orbis Medicines. The round was led by New Enterprise Associates (NEA), with participation from new investors including Eli Lilly and Company, Cormorant, the Export and Investment Fund ofDenmark, alongside existing...
PR Newswire
06/01/2025

MolecuLight Secures $27.5 Million From Hayfin, a Leading Healthcare…

MolecuLight's innovative fluorescence imaging devices are transforming the way healthcare providers detect and treat infections. By providing real-time visualization of harmful bacteria in all wound types, these devices empower clinicians to make informed decisions and improve patient outcomes while reducing cost-to-care1,2. This includes shortened healing times, reduced use of unnecessary antibiotics, complication avoidance, and minimized failure of skin substitutes products1,3,4.. ...
PR Newswire
06/01/2025

Ultimovacs ASA – Disclosure of voting rights of Extraordinary General Meeting

Oslo, January 6, 2025:In connection with the Extraordinary General Meeting of Ultimovacs ASA to be held on January 9, 2025, Jónas Einarsson, Chair of the Board of Directors, has so far received proxy-based voting rights without voting instructions for 8,020,964 shares, representing 23.31% of the total voting rights in the company.The proxies are only valid for the Extraordinary General Meeting on January 9, 2025. This information is subject of the disclosure requirements pursuant to...
Nasdaq GlobeNewswire
06/01/2025

Momcozy 2024 Year in Review: Capturing the Power of Comfort and Growth

Throughout 2024, Momcozy hosted impactful events globally to honor and support mothers. In March, the "Cozy Mom: Her Infinite Power" campaign, in partnership with Marie Claire, shared inspiring stories of diverse women embracing their true selves. In May, the "Cozy Village: From Cozy Me to Cozy We" philosophy, celebrated for Mother's Day, emphasized community support alongside partners like Babylist and PSI, highlighting the collective effort needed in the parenting journey…
PR Newswire
06/01/2025

Oculis Announces Positive OCS-05 Phase 2 ACUITY Trial in Acute Optic Neuritis…

OCS-05 showed a favorable safety and tolerability profile compared to placeboAchieved statistically significant results on key secondary efficacy endpoints compared to placebo, including objective structural measures of retinal thickness and visual improvementIND clearance from FDA enables initiation of clinical development in the U.S as part of a global development program Planning next steps for OCS-05 as a potential first-in-class neuroprotective therapy for acute optic...
Nasdaq GlobeNewswire
06/01/2025

HOOKIPA Pharma Inc. (“HOOKIPA”) Rule 2.9 Announcement – Amendment

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION. 6 January 2025 HOOKIPA Pharma Inc. (“HOOKIPA”)Rule 2.9 Announcement – Amendment NEW YORK and VIENNA, Austria, Jan.06, 2025(GLOBE NEWSWIRE) -- The following amendment has been made to the 'Rule 2.9 Information' disclosed by HOOKIPA in the Rule 2.4 announcement made on 2...
Nasdaq GlobeNewswire
06/01/2025

Santhera Enters into Supply and Distribution Agreement for AGAMREE® (Vamorolone)…

Pratteln, Switzerland, January 6, 2025 – Santhera Pharmaceuticals (SIX: SANN) announces the signing of an exclusive agreement with Clinigen Group to manage the supply and distribution of AGAMREE® (vamorolone) in countries where the product is not otherwise commercially available. Santhera Pharmaceuticals and Clinigen Group announce that they have signed a Supply and Distribution Agreement for AGAMREE in countries where the product can currently not be commercially obtained via Santhera or...
Nasdaq GlobeNewswire
06/01/2025

Press release: Sequana Medical Announces Key Opinion Leader (KOL) Webinar to…

Sequana Medical Announces Key Opinion Leader (KOL) Webinar to Discuss alfapump® US Commercial Roll-Out on January 8 that 15:00 CET / 09:00 ESTWebinar to discuss US commercial roll-out following FDA approval of alfapump ®for the treatment of recurrent or refractory ascites due to liver cirrhosis in December 2024alfapump has received PMA Approval 1and FDA Breakthrough Device DesignationCall participants include Dr. Saab, David Geffen School of Medicine, UCLA & Dr...
Nasdaq GlobeNewswire
06/01/2025

NMD Pharma Announces FDA Orphan Drug Designation Granted to NMD670 for the…

NMD Pharma Announces FDA Orphan Drug Designation Granted to NMD670 for the Treatment of Patients with Charcot-Marie-Tooth Disease This is the 2 ndorphan drug designation granted to the skeletal muscle-specific drug therapy NMD670Under this newly granted orphan drug designation, NMD670 is currently being evaluated in a Phase 2 clinical trial in adult patients with any genetically confirmed Type 1 or Type 2 CMT subtypeNMD Pharma has three ongoing global clinical trials investigating...
Nasdaq GlobeNewswire
06/01/2025

Amorepacific Named CES 2025 Innovation Award Honoree

'WANNA-BEAUTY AI,' an Innovation Award Honoree in the AI category, is a voice-activated chatbot application that leverages generative AI to help customers discover their ideal makeup looks and experience personalized virtual try-ons. The application first analyzes skin tone, facial features, and proportions with user photos. The AI solution, trained with data from makeup artists, then offers makeup recommendations and virtual try-ons. Users can also virtually try on someone else's makeup on…
PR Newswire
06/01/2025

Coway Named a CES 2025 Innovation Awards Honoree

This year, Coway has been named a CES® 2025 Innovation Awards Honoree for three conceptual products that reflect the company's future-forward technological direction, one that prioritizes providing the utmost in consumer convenience alongside optimized, fully customizable life solutions. This year, Coway has been named a CES® 2025 Innovation Awards Honoree for three conceptual products that reflect the company's future-forward technological direction, one that prioritizes providing the utmost...
PR Newswire
06/01/2025

MAMMOTION Unveils Next-Generation Robotic Mowers with New AI Vision Technology…

Smarter Lawn Care with UltraSense AI Vision Smarter Lawn Care with UltraSense AI Vision MAMMOTION's UltraSense AI Vision is designed to simplify lawn maintenance, offering professional-grade results with advanced AI technology. Features include: Introducing the 2025 Product Lineup MAMMOTION's expanded lineup now includes four distinct robot lawnmower series, each tailored to meet specific lawn care needs. LUBA 2 AWD Series:Designed for large and complex lawns (up to 2...
PR Newswire
06/01/2025

Ultimovacs ASA: Regarding the extraordinary general meeting on 9 January 2025

Oslo, 5 January 2025: Reference is made to the stock exchange notice published by Ultimovacs ASA on 19 December 2024 regarding the call for an extraordinary general meeting to be held on 9 January 2025 at 09:00 CET (the "EGM"). As described in the previously published EGM notice, one additional proposal for a board member would be announced prior to the EGM. The complete proposal for the board of directors is now complete and attached hereto. For further information, please seewww...
Nasdaq GlobeNewswire
05/01/2025

Episode Two "The Wisdom of the Shanghai School" of CMG's "China TCM Show"…

"The Wisdom of the Shanghai School" episode highlights the inclusiveness and openness of the Shanghai-style of TCM. In particular, it shows how the Shanghai School integrates Eastern and Western medicine in intuitive ways. The episode also presents the achievements and spirit of the Shanghai School to viewers. "The Wisdom of the Shanghai School" episode highlights the inclusiveness and openness of the Shanghai-style of TCM. In particular, it shows how the Shanghai School…
PR Newswire
04/01/2025

LILYSILK Marks Third Anniversary of its Partnership with TerraCycle®, Expands…

The recycling process is simple: register at TerraCycle.com, pack your LILYSILK textiles, and send them to TerraCycle using a prepaid shipping label. The textiles are then cleaned, sorted, and recycled into raw materials for products like mattress fillers, pet bedding, and sporting equipment. This free program helps reduce waste and keeps valuable materials out of landfills. The recycling process is simple: register at TerraCycle.com, pack your LILYSILK textiles, and send them to TerraCycle...
PR Newswire
04/01/2025
Altri  Comunicati